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A subset of omphalocele infants has respiratory decompensation after the ﬁrst week of life and PHN is
diagnosed. Infection may initiate decompensation. In some, PHN is distinct from pulmonary hypoplasia
as they oxygenate on room air for some time after birth. With aggressive treatment and follow-up, PHN
can resolve. The late diagnosis of PHN in infants with omphalocele is previously unappreciated and
deserves further study.
Ó 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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An omphalocele is a ventral defect of the umbilical ring with
herniation of the abdominal viscera [1]. For omphalocele infants,
respiratory failure at birth is an independent predicator of mortality
[2]. Pulmonary hypoplasia, deﬁned as incomplete lung development, with decreased broncho-pulmonary segments and diminished alveolar septation, may contribute to respiratory insufﬁciency
after birth in some, but not all, omphalocele infants [3]. Pulmonary
hypertension (PHN), diagnosed between the second and seventh
day after birth, is an independent predictor of mortality in
omphalocele infants and may represent another cause of respiratory insufﬁciency [4,5].
A subset of omphalocele infants has no evidence of pulmonary
hypoplasia or hypertension at birth, but exhibit respiratory insufﬁciency after the ﬁrst week of life. These infants may have a late diagnosis
of PHN. Although respiratory insufﬁciency is considered an important
factor in omphalocele outcomes, little is known about this entity.
We report six infants with an omphalocele and a late diagnosis
of pulmonary hypertension. On the basis of the ﬁndings of these
cases and a literature review, strategies to promote recognition and
treatment of this entity are discussed.

* Corresponding author. Pediatric Surgery, Rm. 21111 Coleman Pavilion, 11175
Campus St., Loma Linda, CA 92354, USA.
E-mail address: jbaerg@llu.edu (J.E. Baerg).

1. Materials and methods
After Institutional Review Board approval, a retrospective review was performed of 115 infants born with omphalocele at two
academic children’s hospitals between 2000 and 2011. Fifty-eight
were excluded because an echocardiogram was performed on the
ﬁrst day of life, during the phase of transitional circulation. No other
echocardiograms were performed in these 58. In 51, PHN was
diagnosed between day of life two and seven and they were
excluded. The six included infants had a diagnosis of PHN after the
ﬁrst week of life.
Infant demographic data, cardiopulmonary status at birth,
clinical deterioration, laboratory septic markers, culture data, Btype natriuretic peptide (BNP) levels, transthoracic echocardiograms, and clinical outcomes were recorded. Prenatal ultrasound
and magnetic resonance imaging (MRI) reports were sought in the
medical records.
The initial preoperative transthoracic echocardiograms were
obtained. After recording the initial reports, a single cardiologist
interpreted each one in blinded fashion, to eliminate reviewer
variability in the diagnosis of PHN. Pulmonary hypertension
was deﬁned as ﬂattening of the inter-ventricular septum during
systole and/or a tricuspid regurgitant jet (TR) with an estimated
right ventricular pressure greater than 40 mm when observed
in the setting of hypoxemia [6]. The omphalocele defect was
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deﬁned as a giant defect when 75% of the liver was visible in
the sac [1].
A search of the published literature pertaining to omphalocele
and pulmonary hypertension was performed using the PubMed
online database. The language was limited to English, but year of
publication was not limited.
2. Results
Demographic data are presented in Table 1. There were three
females and three males born between 35 and 39 weeks gestational
age. The median gestational age was 37.5 weeks, the median birth
weight was 2502 g and the median weight/length z-score was 0.53.
All were prenatally diagnosed by ultrasound and four met the
criteria for giant omphalocele. None had prenatal MRI imaging
available for review. All had normal chromosomal studies and no
evidence of aneuploidy.
Infant cardiopulmonary data at birth and during the ﬁrst week
of life are presented in Table 2. All six infants maintained an oxygen
saturation of 100% on the ﬁrst day of life. Three were breathing
room air. Three required intubation at birth and conventional mechanical ventilation. The sixth infant was extubated and breathing
room air between DOL 3 and 15.
Three infants required no cardiopulmonary support at birth and
nippled their feeds between day of life three and six. Three infants
that required ventilator support at birth, tolerated gavage or
nasojejunal (NJ) feeds between day of life 2 and 46. Infants one and
three were diagnosed with Fryn and Goltz Syndrome, respectively.
Four had a transthoracic echo on day of life two and two on day
of life three. All were initially diagnosed as having no pulmonary
hypertension. A blinded retrospective review of the initial echocardiogram tapes by one cardiologist for this series, found subtle
signs of PHN in four infants (Table 2). All congenital heart defects
were simple, non-ductal dependent anomalies without hemodynamic signiﬁcance.
Cardiopulmonary function deteriorated in all six infants
(Table 3). Further investigations, imaging and treatment proceeded
according to clinician speciﬁc practice. All six infants had laboratory
studies consistent with infection from culture proven urosepsis,
bacteremia or pneumonia, on the day of deterioration.
Transthoracic echocardiography was performed between DOL 9
and 52 (median: DOL 15), and revealed PHN in all six. One underwent computed tomography angiography (CT-angio) on DOL 20.
The fourth infant deteriorated with sepsis in the second week of
life, and the PHN persisted. This was appreciated when she underwent a CT angio and cardiac catheterization (cath) on DOL 117
and was found to have severe PHN. The CT angio revealed a structurally normal heart in each infant.
Treatment of sepsis was broad spectrum antibiotics in all six
cases which was subsequently guided by available culture results.
Treatment of PHN in all six included nitric oxide, sildenaﬁl,
inotropes (dopamine and dobutamine) and milrinone (Table 3).
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All infants received paralytics with vecuronium and sedation
with narcotics and versed to promote better ventilation during
escalation of treatment. The results of any BNP levels were sought
in the medical records, but none were obtained. The third infant
received Esmolol for supraventricular tachycardia (SVT) that
occurred when she was septic.
The three that required conventional ventilation at birth, escalated to high frequency oscillatory ventilation (HFOV) (infants 4e6).
When respiratory failure worsened in the sixth infant, a decision
was made for veno-venous ECMO.
Infant outcomes are presented in Table 4. All three mortalities
died within two months after birth at a median of 22 days (range:
18e51 days). All had severe PHN at the time of death and none
responded to aggressive treatment for PHN and sepsis. None were
stable for repair of the omphalocele defect. One suffered an
omphalocele sac rupture and was debrided several days before his
demise and one died on ECMO.
The sixth infant developed persistent tachycardia on DOL 13 and
was intubated emergently on DOL 14. An endotracheal tube culture
was positive for Group B streptococcus. Despite HFOV and an Fi02 of
100%, his respiratory failure worsened. An echocardiogram
conﬁrmed severe PHN. The infant was placed on veno-venous
ECMO on DOL 15.
The decision for veno-venous ECMO was based on the fact that
the infant had been extubated and ventilating well during the ﬁrst
week of life. Review of the literature revealed a paucity of data to
guide the clinical management. It appeared the new-onset of PHN
may respond to oxygenation and sepsis treatment. Within 24 h,
the infant developed circuit disseminated intravascular coagulation with platelet consumption, combined with clots in the arterial
side of the circuit. A complete circuit change was done. Serial
echocardiograms revealed worsening PHN, and clots in the right
ventricle extending through the tricuspid valve. Due to worsening
PHN and ECMO complications, a recommendation was made to
withdraw care and the infant died on the third day of ECMO
support (DOL 18).
Follow-up for three survivors ranged from 540 to 1219 days
with a median of 868 days. Follow-up echocardiograms revealed
the PHN resolved for all three, and they are tolerating full enteral
feeds. Two have tracheostomies and require support for chronic
respiratory insufﬁciency. Infants 3 and 4 have mild neurologic
impairment.
Infant 3 underwent a primary omphalocele repair on DOL 38.
One week after repair, the infant returned to the operating room for
a bowel obstruction with perforation. The infant required a bowel
resection, but recovered and was discharged from hospital on DOL
59. There was no clinically signiﬁcant PHN at this time. Sildenaﬁl
was discontinued before discharge.
Prior to discharge, this infant was diagnosed by skin biopsy with
Goltz syndrome, a craniofacial syndrome (facial dermal hypoplasia). The infant had a cleft lip, a club foot and syndactyly. A brain
MRI revealed mild frontal/temporal lobe atrophy, and bilateral optic

Table 1
Demographics of six infants with omphalocele and a late diagnosis of PHN.
Gender

Gestational age
(weeks)

Birth
weight (g)

Weight/length
z-score at birth

Inborn

Giant defect

Age at diagnosis by
prenatal US (weeks)

Prenatal US report, omphalocele contents
and heart evaluation

F
M

35
39

2644
3775

0.53
0.55

No
Yes

No
Yes

16
18

F
F

39
37

2325
2448

No
Yes

No
Yes

20
22

M
M

35
38

2555
2299

No
No

Yes
Yes

20
12

Small bowel, hydronephrosis, two vessel cord, ASD
Liver, small bowel, stomach, polyhydramnios,
normal heart
Small bowel, small VSD
Liver, large and small bowel, hydronephrosis,
oligohydramnios, Prominent Right atrium
Liver, large and small bowel, small ASD
Liver, small bowel, stomach, normal heart

0.28
1.5
0.75
0.53
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Table 2
Infant cardiopulmonary status at birth and during the ﬁrst week of life.
Apgar 1 min

Apgar 5 min

Intubated at birth

Fi02 at birth (%)a

Initial echo report

Blinded echo
review

Echo: CHD

DOLc ﬁrst feeding

Genetic syndrome

8

9

No

21

No PHN

Mild PHN

3

Fryn syndrome

8
8
1

8
9
7

No
No
Yes

No PHN
No PHN
No PHN

No PHN
Mild PHN
Mild PHN

3
6
46 (NJ feed)

Goltz syndrome with cleft lip

3

8

Yes

No PHN

No PHN

Small ASD

2 (gavage)

8

5

Yes

21
21
Conv vent
55
Conv vent
40
Conv vent
30
Extb DOL 3e15

Dextrocardia
Small ASD
Normal
Small VSD
Normal

No PHN

Mild PHN

Small PFO

7 (gavage)

a
b
c

Infants 1e3 breathed room air at birth.
Extubated.
Infants 1e3 nippled feedings.

nerve hypoplasia, but normal spectroscopy. Her initial EEG was
abnormal. She failed her hearing test due to conductive hearing loss
in the left ear. She required a gastrostomy tube for feeding. She was
followed by neurology every three months and attended early
physiotherapy and speech therapy.
At 19 months, she was walking with assistance, eating independently with a spoon and speaking several words. Her follow-up
EEG was normal. At 10 years she attended regular school and had
mild cognitive, motor, speech and hearing deﬁcits. She has no
respiratory difﬁculties.
Infant 4 has a giant omphalocele and repair is pending. This
infant was diagnosed with PHN on ECHO at DOL 13 when she
deteriorated with sepsis, and underwent tracheostomy for chronic
lung disease at DOL 71. However, her persistent PHN was better
appreciated by clinicians after she underwent cardiac catheterization at DOL 171. At the time of catheterization, she required
100% Fi02 and nitric oxide at 20 ppm. Her prognosis was considered very poor and her status was “do not resuscitate”.
After the catheterization conﬁrmed severe PHN, she began longterm sildenaﬁl and Bosentan therapy. By ten months, her Fi02
decreased to 25% and nitric oxide was discontinued. Serial echocardiograms guided the weaning of sildenaﬁl. She was discharged
to a chronic care facility at 10 months. At 2 years of age, after the
PHN had improved, she underwent an open left thoracic CDH repair
for a previously undiagnosed CDH and recovered well. At 3 years,

she has mild PHN on echocardiogram, her Fi02 is 21% and she
continues to take sildenaﬁl. Her Bosentan was discontinued. Her
pulmonary function studies are consistent with restrictive lung
disease.
At 10 months of age, before hospital discharge, this infant underwent a brain MRI which revealed hypoxic ischemic encephalopathy (HIE). She required full gastrostomy tube feeds, had motor,
cognitive and speech delays, and could sit with assistance, but
appeared to track and hear normally. She was followed by
neurology every 3 months and received physio and speech therapy.
By 2 years, she was walking with assistance, and has only mild gross
motor and cognitive delays.
Infant 5 underwent staged repair with complete closure of the
omphalocele on DOL 151 and no other operations were performed.
Sildenaﬁl was discontinued before discharge. The child was discharged with a tracheostomy but no further long-term follow-up
neurologic or respiratory evaluations were available.
3. Discussion
Respiratory insufﬁciency is a known complication in infants
with an omphalocele, but the causes are not well understood [1].
Omphalocele infants with MR imaging-based observed/expected
total fetal lung volumes (O/E TFLV) below 50% have signiﬁcantly
lower Apgar scores and prolonged ventilation [7]. This ﬁnding is

Table 3
Cardiopulmonary, sepsis, ventilation and inotrope data at deterioration.
Intubated DOL

Fi02a

ECHO DOL

12b

40

18

4

9

75

9

5

4

40

15

3

Intubated at birthc

HFOV
60

13

9

Intubated at birth

HFOV
65

52

5

Intubated at birth

HFOV
100

15

2

a
b
c
d

Blood gas:
base excess

Infants 1e3 placed on conventional ventilation.
CT Angio on DOL 20.
CT Angio and Cardiac Cath on DOL 117.
Supraventricular tachycardia

Culture result

WBC/CRP

Vent (days)

Inotropes (days)

Milrinone and
other (days)

Urine
Enterobacter
Blood
Methicillin resistant Staph
Blood
Coagulase negative
Staph
Trachea
Staph aureus
(pneumonia)
Blood
Coagulase negative
Staph
Trachea
Group B Strep
(pneumonia)

11/4

10

4

4

22 w bands/24

42

8

10

19/20

6

4

Esmolol
SVTd on DOL 15

12/17

868 (trach DOL 71)

10

11

19/16

200 (trach DOL 52)

5

5

18/18.4

4 (V-V ECMO)

3

3
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Table 4
Outcomes and day of life (DOL) follow-up (F/U) evaluation.
Outcome
DOL F/U

Last echo
DOL

Medication
respiratory status

Died
22
Sepsis
Died
51
Sepsis
Alive
1219
Alive
868

PHN
22

Alive
540
Died
18
Sepsis
a
b
c

Neurologic status at
hospital d/c (MRI results)

Omphalocele Repairs
DOL

Feeding status at F/U

Fi02 100%

Not repaired

NPO

PHN
48

Fi02 100%

Not repaired

NPO

Sac rupture-debrided
46

No PHN
30
No PHN
727

No meds
Room air
Sildenaﬁl Fi02 25%

Primary and G-tube
38
Not repaired

Full G-tube feeds

SBO,b malrotation, perforation
45
Left CDHc repair
800

No PHN
100
PHN
17

No meds
Room air
V-V ECMO

Staged
Final 151
Not repaired

Nippling full feeds

Frontal lobe
atrophy
HIEa
Motor and cognitive
delay

Full NJ feeds

Other operations
DOL

NPO

Hypoxic ischemic encephalopathy (HIE).
Small bowel obstruction (SBO).
Congenital diaphragmatic hernia (CDH).

considered predictive of increased postnatal morbidity in omphalocele infants. These measurements represent incomplete lung
development (pulmonary hypoplasia) which may contribute to
respiratory insufﬁciency in some omphalocele infants, but is not a
complete explanation. In this setting, a ﬁxed respiratory insufﬁciency exists at birth.
In contrast, four infants in our series experienced little inﬂuence
from pulmonary hypoplasia. They ventilated well on room air at
birth, had satisfactory Apgar scores and nippled their ﬁrst feedings,
including one that subsequently required ECMO support.
A mortality rate as high as 25% is reported for omphalocele infants [1]. Pulmonary hypertension (PHN) is associated with mortality in omphalocele infants, independent of pulmonary
hypoplasia or other causes, but few studies exist [4].
Pulmonary hypertension is an independent risk factor for mortality in infants with late-onset sepsis [8]. The mortality rate for
infants with sepsis is between 7 and 12% and increases if PHN develops. Group B streptococcus sepsis also carries a high risk of
complications from the development of PHN [9]. Three infants in
this series with risk factors for mortality died. All had sepsis, PHN,
one suffered a sac rupture and one was culture positive for Group B
streptococcus.
The explanation for worsening PHN in omphalocele infants remains unknown. In some, isolated PHN in the absence of a CHD has
been documented on prenatal echocardiogram [10]. The developing
lung is subject to multiple genetic, pathological and environmental
inﬂuences that can adversely affect development leading to PHN.
New classiﬁcations of PHN may account for this diversity such as
maladaptation, excessive muscularization and remodeling, and
vascular hypoplasia as observed in CDH [11]. One infant responded
well to long-term sildenaﬁl and Bosentan, an endothelin receptor
antagonist that improves pulmonary vascular resistance through
remodeling. This favorable response implies a component of muscularization may contribute to PHN in omphalocele infants. Recent
experience suggests Bosentan is well-tolerated and effective for
pediatric PHN [12].
All six infants had culture proven evidence of sepsis, worsening acidosis, elevation of inﬂammatory markers and escalation
of cardiopulmonary support. Echocardiograms performed at
deterioration conﬁrmed signiﬁcant PHN. Although this is a small
retrospective series, it reveals an important, previously unreported pattern, of worsening PHN with sepsis in omphalocele
infants.

One infant died after three days of veno-venous ECMO support
at eighteen days of age. Review of the ELSO database revealed only
eleven infants with omphalocele was placed on ECMO, all for PHN,
and all since 2011 [13]. Veno-arterial ECMO was used for all but one,
and seven (64%) were weaned from ECMO, but only two (18%)
survived to discharge. Four of eleven in the ELSO series had a CDH in
addition to an omphalocele. One infant in this series had omphalocele, severe PHN and a late-diagnosed CDH. Multiple factors may
inﬂuence the developing lung and etiology of PHN.
Pulmonary hypertension is more commonly reported in giant
omphalocele infants [5]. However, three infants in this series met
the deﬁnition of non-giant omphalocele and one died. In a recent
series, 28 omphalocele infants had PHN but only 17 (61%) met the
deﬁnition of a giant defect, 11 (39%) were diagnosed with PHN
by strict criteria, and had a non-giant omphalocele [4]. The fact
that PHN occurs with non-giant omphaloceles merits further
investigation.
The association of PHN with mortality in omphalocele infants
is only recently appreciated. Associations for both PHN and
omphalocele, and PHN and sepsis, are reported [4,5,8]. When
these combined diagnoses exist, PHN should be sought and
treated. Echocardiography should be performed after the second
day of life, to allow resolution of the transitional circulation, and
repeated if respiratory status worsens. Serial monitoring of inﬂammatory markers and markers of worsening right heart function may allow early detection and treatment of worsening PHN
and/or sepsis.
Serial biomarkers such as B-type natriuretic peptide (BNP) have
revealed prognostic value in PHN and serum levels decrease with
functional improvement [14]. Measures of BNP levels provide a
biomarker that differentiates infants with PHN physiology from
those with pulmonary causes of respiratory failure and monitors
worsening right heart function [11]. No BNP levels were obtained in
this retrospective series, but as awareness of PHN grows, serial BNP
levels should be part of a PHN care strategy in omphalocele infants.
The detection of delayed PHN should be aggressively managed
as suggested by this series where only 50% survived despite treatment with nitric oxide, sildenaﬁl and milrinone, escalating to ECMO
in one case. One received the endothelin-receptor antagonist,
Bosentan and sildenaﬁl, for over one year and recovered. Since
multiple mechanisms are involved in the pathogenesis of PHN, drug
combinations with different sites of action should be considered in
its management [15].
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Follow-up echocardiograms revealed PHN resolved in the three
survivors, which implies a reversible phenomenon. If successfully
supported, an infant may survive. Whether the non-survivors
developed irreversible physiology is unknown, but based on these
infants, one should consider every option in the armamentarium
for treating PHN when it appears later in the course of omphalocele
infants.
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